« Return to News | Awards & Advancement

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

Niewel is a medical oncologist with more than 20 years experience in clinical research in oncology and other major therapeutic areas. As medical director, Niewel will serve as a therapeutic expert in the oncology area in the medical department and will be field-based in Munich, Germany.

“I am extremely pleased to have Manuela’s strong expertise in our medical department as it will provide our clients with a broader oncology experience to help them overcome the complexities often found in oncology trials,” said Aize Smink, COO of Chiltern. “In previous roles, Manuela served as senior medical director where she was responsible for phase I-III oncology trials and has led clinical research teams for both pharmaceutical and clinical research companies.”

Bull joins Chiltern with more than 20 years experience in the pharmaceutical and CRO industries. She is field-based in the U.K. and a holds a BA degree in Business Studies from U.K.’s Westminster University.

“It gives me great pleasure to welcome Lisa Bull as director of strategic partnerships,” said Stuart McGuire, vice president of global business development, Chiltern. “Lisa has a thorough understanding of clinical development in multiple therapeutic areas and geographies, as well as a strong track record in establishing long standing and successful partnerships.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.